stoxline Quote Chart Rank Option Currency Glossary
  
Actuate Therapeutics Inc (ACTU)
9.295  -0.085 (-0.91%)    02-06 10:01
Open: 9.45
High: 9.45
Volume: 1,429
  
Pre. Close: 9.38
Low: 9.09
Market Cap: 182(M)
Technical analysis
2025-02-06 10:46:03 AM
Short term     
Mid term     
Targets 6-month :  11.8 1-year :  13.7
Resists First :  10.1 Second :  11.72
Pivot price 9.41
Supports First :  7.47 Second :  6.21
MAs MA(5) :  9.27 MA(20) :  9.08
MA(100) :  8.23 MA(250) :  0
MACD MACD :  0.2 Signal :  0.2
%K %D K(14,3) :  37.7 D(3) :  39.3
RSI RSI(14): 53.5
52-week High :  11.72 Low :  5.51
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ACTU ] has closed above bottom band by 45.4%. Bollinger Bands are 22.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.52 - 9.56 9.56 - 9.59
Low: 8.75 - 8.79 8.79 - 8.83
Close: 9.36 - 9.44 9.44 - 9.5
Company Description

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.

Headline News

Thu, 06 Feb 2025
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February - GlobeNewswire

Tue, 28 Jan 2025
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga

Fri, 24 Jan 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Wed, 08 Jan 2025
Actuate Therapeutics (NASDAQ:ACTU) Shares Down 2.1% - What's Next? - MarketBeat

Tue, 17 Dec 2024
Actuate Therapeutics Announces Positive Interim Phase 2 - GlobeNewswire

Tue, 26 Nov 2024
Actuate Therapeutics to be Added to Russell 2000® Index - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 20 (M)
Shares Float 7 (M)
Held by Insiders 18.6 (%)
Held by Institutions 53 (%)
Shares Short 20 (K)
Shares Short P.Month 13 (K)
Stock Financials
EPS -1.47
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -58.92
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -19 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -6.37
PEG Ratio 0
Price to Book value -0.16
Price to Sales 0
Price to Cash Flow -9.52
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android